Volume 21 Issue 9
Sep.  2023
Turn off MathJax
Article Contents
WANG Hang, XU Qixia, LI Xiaoqing, WANG Yueyue. Analysis of long-term prognostic factors in patients with acute pulmonary embolism[J]. Chinese Journal of General Practice, 2023, 21(9): 1466-1469. doi: 10.16766/j.cnki.issn.1674-4152.003147
Citation: WANG Hang, XU Qixia, LI Xiaoqing, WANG Yueyue. Analysis of long-term prognostic factors in patients with acute pulmonary embolism[J]. Chinese Journal of General Practice, 2023, 21(9): 1466-1469. doi: 10.16766/j.cnki.issn.1674-4152.003147

Analysis of long-term prognostic factors in patients with acute pulmonary embolism

doi: 10.16766/j.cnki.issn.1674-4152.003147
Funds:

 2011BAI11B17

 2016YFC0905600

  • Received Date: 2023-01-04
    Available Online: 2023-10-19
  •   Objective  To analyze the clinical data and laboratory tests of patients with acute pulmonary embolism (APE) in different conditions, explore the influencing factors of adverse events in patients with APE, and carry out reasonable treatment to improve the prognosis.  Methods  A single center of the First Affiliated Hospital of Bengbu Medical College enrolled 202 patients with APE in the national "Twelfth Five-Year Plan" and "Thirteenth Five-Year Plan" registration studies from May 2012 to June 2019, of which 191 patients completed at least 6-month follow-up, and 146 patients completed 3-year follow-up. The follow-up outcome was all-cause mortality. Univariate and multivariate regression were used to analyze the impact of clinical data and laboratory indicators on the long-term prognosis of patients.  Results  A total of 191 patients were followed up at 6 months after diagnosis: 164 cases survived and 27 died. Multivariate COX regression showed that underlying disease of malignancy or chronic cardiopulmonary disease had a significant effect on APE 6-months prognosis (short-term prognosis, P < 0.05). Totally 146 patients completed the 36-month follow-up, 111 survived and 35 died. Multivariate COX regression showed that the combination of malignant tumors, chronic cardiopulmonary diseases, and low serum albumin levels had a significant impact on the 36-month prognosis of patients. The independent risk factors for the long-term prognosis of APE included combination of malignant tumors, chronic cardiopulmonary diseases, and low serum albumin levels.  Conclusion  The combination of malignant tumors, chronic cardiopulmonary diseases, and low serum albumin levels are independent factors affecting the long-term prognosis of pulmonary embolism. Combination of malignant tumors and chronic cardiopulmonary diseases, both long-term and short-term prognosis are poor. Low serum albumin level is an adverse factor for long-term prognosis in acute pulmonary embolism.

     

  • loading
  • [1]
    KONSTANTINIDES S V, MEYER G, BECATTINI C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society[J]. Eur Heart J, 2020, 41(4): 543-603. doi: 10.1093/eurheartj/ehz405
    [2]
    ZHAI Z, WANG D, LEI J, et al. Trends in risk stratification, in-hospital management and mortality of patients with acute pulmonary embolism: an analysis from the China pulmonary thromboembolism registry study[J]. Eur Respir J, 2021, 58(4): 1-11.
    [3]
    李小晴, 许启霞, 庞颖颖. 肺血栓栓塞症预后因素分析[J]. 中华全科医学, 2017, 15(6): 1022-1026.

    LI X Q; XU Q X. Analysis of prognostic factors in patients with pulmonary thromboembolism[J]. Chinese Journal of General Practice, 2017, 15(6): 1022-1026.
    [4]
    中华医学会呼吸病学分会肺栓塞与肺血管病学组, 中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会, 全国肺栓塞与肺血管病防治协作组. 肺血栓栓塞症诊治与预防指南[J]. 中华医学杂志, 2018, 98(14): 1060-1087. doi: 10.3760/cma.j.issn.0376-2491.2018.14.007

    Pulmonary embolism and pulmonary vascular Disease Group, Chinese Medical Association Respiratory Branch, Pulmonary embolism and pulmonary Vascular Disease Working Committee, Chinese Medical Doctor Association Respiratory Physician Branch, National pulmonary embolism and pulmonary vascular disease Prevention and Treatment Collaboration group. Guidelines for diagnosis, treatment and prevention of pulmonary thromboembolism[J]. Chinese Medical Journal, 2018, 98(14): 1060-1087. doi: 10.3760/cma.j.issn.0376-2491.2018.14.007
    [5]
    张拓北. 肺癌患者并发肺栓塞的影响因素及预后[J]. 中国卫生工程学, 2022, 21(1): 75-77. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWX202201023.htm

    ZHANG T B. Influencing factors and prognosis of pulmonary embolism in patients with lung cancer[J]. Chin J Public Health Eng, 2022, 21(1): 75-77. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWX202201023.htm
    [6]
    JACK L, LOCKARD C. Thrombocytosis assiciated with malignant[J]. Arch Intern Med, 1964, 23(9): 497-500.
    [7]
    ALBERTSEN I E, NIELSEN P B, SOGAARD M, et al. Risk of recurrent venous thromboembolism: a Danish nationwide cohort study[J]. Am J Med, 2018, 131(9): 1067-1074. doi: 10.1016/j.amjmed.2018.04.042
    [8]
    张丽, 万毅新, 王虹. 肺栓塞患者合并肿瘤与非肿瘤的危险因素分析[J]. 甘肃医药, 2022, 41(10): 881-884. https://www.cnki.com.cn/Article/CJFDTOTAL-GSYY202210006.htm

    ZHANG L, WAN Y X, WANG H. Analysis of risk factors for pulmonary embolism patients with tumor and non-tumor[J]. Gansu Med J, 2022, 41(10): 881-884. https://www.cnki.com.cn/Article/CJFDTOTAL-GSYY202210006.htm
    [9]
    付萌, 庞桂芬. 慢性阻塞性肺疾病合并肺栓塞临床诊治进展[J]. 临床医药文献电子杂志, 2018, 5(87): 186-188. https://www.cnki.com.cn/Article/CJFDTOTAL-LCWX201887164.htm

    FU M, PANG G F. Advances in clinical diagnosis and treatment of chronic obstructive pulmonary disease complicated with pulmonary embolism[J]. Journal of Clinical Medicine Literature, 2018, 5(87): 186-188. https://www.cnki.com.cn/Article/CJFDTOTAL-LCWX201887164.htm
    [10]
    朱晓敏, 罗健, 李苗苗, 等. 慢性阻塞性肺疾病患者并发静脉血栓栓塞症危险因素的Meta分析[J]. 中华护理杂志, 2019, 54(5): 746-752. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHHL201905031.htm

    ZHU X M, LUO J, LI M M, et al. Meta-analysis of risk factors for venous thromboembolism in patients with chronic obstructive pulmonary disease[J]. Chin J Nurs, 2019, 54(5): 746-752. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHHL201905031.htm
    [11]
    KELLER K, BEULE J, COLDEWEY M, et al. The risk factor age in normotensive patients with pulmonary embolism: effectiveness of age in predicting submassive pulmonary embolism, cardiac injury, right ventricular dysfunction and elevated systolic pulmonary artery pressure in normotensive pulmonary embolism patients[J]. Exp Gerontol, 2015, 69: 116-121. doi: 10.1016/j.exger.2015.05.007
    [12]
    王小强, 王艳, 张艳东, 等. 炎症因子检测对慢性阻塞性肺疾病急性加重期的诊断价值[J]. 山西医药杂志, 2017, 46(7): 802-804. https://www.cnki.com.cn/Article/CJFDTOTAL-SXYY201707029.htm

    WANG X Q, WANG Y, ZHANG Y D, et al. Diagnostic value of inflammatory factor detection in acute exacerbation of chronic obstructive pulmonary disease[J]. Shanxi Med J, 2017, 46(7): 802-804. https://www.cnki.com.cn/Article/CJFDTOTAL-SXYY201707029.htm
    [13]
    LITUS E A, PERMYAKOV S E, UVERSKY V N, et al. Intrinsically disordered regions in serum albumin: what are they for?[J]. Cell Biochem Biophys, 2018, 76(1-2): 39-57.
    [14]
    NICHOLSON J P, WOLMARANS M R, PARK G R. The role of albumin in critical illness[J]. Br J Anaesth, 2000, 85(4): 599-610.
    [15]
    庞颖颖, 刘海涛. 生物标志物与急性肺栓塞危险分层及预后的关联性研究[J]. 中华全科医学, 2022, 20(2): 199-201, 281. doi: 10.16766/j.cnki.issn.1674-4152.002311

    PANG Y Y, LIU H T. Association of biomarkers with risk stratification and prognosis of acute pulmonary embolism[J]. Chinese Journal of General Practice, 2022, 20(2): 199-201, 281. doi: 10.16766/j.cnki.issn.1674-4152.002311
    [16]
    KUNUTSOR S K, SEIDU S, KATECHIA D T, et al. Inverse association between serum albumin and future risk of venous thromboembolism: interrelationship with high sensitivity C-reactive protein[J]. Ann Med, 2018, 50(3): 240-248.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)  / Tables(5)

    Article Metrics

    Article views (232) PDF downloads(22) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return